Science Weekly cover image

Are we finally nearing a treatment for Alzheimer’s?

Science Weekly

00:00

What Are the Downsides of Monoclonal Antibodies?

Every drug has its downsides, including actual side effects and monoclonal antibodies are certainly no exception in that. We just do not have the capability to deliver this if it was licensed tomorrow. And then we will need to be able to provide intravenous infusions,. That would really require scaling up a capacity. I am hopeful, but it's going to be quite a challenge.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app